TMO

SELL

Thermo Fisher Scientific Inc

Healthcare · Rank #230 · Analyzed Apr 20, 2026

$526.60

Current Price

$258.93

Intrinsic Value

-27.8%

Upside/Downside

2.5/10

Score

2.5/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree

Quality Score2.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 27.8%

Fair Value Range

Low$115.25

Base (IV)$258.93

High$380.05

Entry Points

Conservative$115.25

Moderate$187.09

Aggressive$258.93

Quality & Moat Breakdown

Return on Equity13.0% → 0.5/1.0

Debt LevelD/E 77 → 0/1.0

Revenue QualityGrowth 4.5%, margin Δ-1.0% +recovery → 1.0/1.0

Moat Strength1.5/5 → 0/1.0

Profit Margins15.0% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.